NasdaqCM - Delayed Quote • USD
Mustang Bio, Inc. (MBIO)
At close: April 22 at 4:00 PM EDT
Pre-Market: 4:53 AM EDT
Insider Purchases Last 6 Months
Shares | Transactions | |
---|---|---|
Purchases | 0 | 0 |
Sales | -- | 0 |
Net Shares Purchased (Sold) | 0 | 0 |
Total Insider Shares Held | 2.35M | -- |
% Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
Shares | |
---|---|
Net Shares Purchased (Sold) | -- |
% Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
Insider | Transaction | Type | Value | Date |
---|---|---|---|---|
FORTRESS BIOTECH, INC. Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 2, 2024 |
WEISS MICHAEL S Director | Stock Award(Grant) at price 0.00 per share. | Indirect | 0 | Jul 5, 2023 |
HERSKOWITZ NEIL Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jul 5, 2023 |
CHILL ADAM J Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jul 5, 2023 |
ZELEFSKY MICHAEL J Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jul 5, 2023 |
ROSENWALD LINDSAY A M.D. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jul 5, 2023 |
LITCHMAN MANUEL Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Apr 24, 2023 |
FORTRESS BIOTECH, INC. Beneficial Owner of more than 10% of a Class of Security | -- | Direct | -- | Jan 6, 2023 |
ROSENWALD LINDSAY A M.D. Director | Purchase at price 0.52 - 0.74 per share. | Direct | 5,607 | Sep 13, 2022 |
WEISS MICHAEL S Director | -- | Indirect | -- | Jul 29, 2022 |
HERSKOWITZ NEIL Director | -- | Direct | -- | Jul 29, 2022 |
CHILL ADAM J Director | -- | Direct | -- | Jul 29, 2022 |
ZELEFSKY MICHAEL J Director | -- | Direct | -- | Jul 29, 2022 |
ROSENWALD LINDSAY A M.D. Director | -- | Direct | -- | Jul 29, 2022 |
LITCHMAN MANUEL Director | -- | Direct | -- | Jun 21, 2022 |
ACHENBACH BRIAN Officer | Sale at price 1.83 per share. | Direct | 8,004 | Dec 14, 2021 |
ACHENBACH BRIAN Officer | -- | Direct | -- | Dec 8, 2021 |
LITCHMAN MANUEL Chief Executive Officer | Purchase at price 2.24 per share. | Direct | 145,600 | Oct 27, 2021 |
ACHENBACH BRIAN Officer | Sale at price 2.28 per share. | Direct | 10,146 | Oct 12, 2021 |
ROSENWALD LINDSAY A Director | Stock Award(Grant) at price 2.58 per share. | Direct | 3,019 | Aug 31, 2021 |
LITCHMAN MANUEL Chief Executive Officer | Stock Award(Grant) at price 2.58 per share. | Direct | 7,085 | Aug 31, 2021 |
LITCHMAN MANUEL Chief Executive Officer | Purchase at price 2.91 per share. | Direct | 250,859 | Jul 30, 2021 |
ROSENWALD LINDSAY A Director | -- | Direct | -- | Jun 28, 2021 |
WEISS MICHAEL S Director | -- | Indirect | -- | Jun 28, 2021 |
HERSKOWITZ NEIL Director | -- | Direct | -- | Jun 28, 2021 |
CHILL ADAM J Director | -- | Direct | -- | Jun 28, 2021 |
ZELEFSKY MICHAEL J Director | -- | Direct | -- | Jun 28, 2021 |
LITCHMAN MANUEL Chief Executive Officer | -- | Direct | -- | Jun 17, 2021 |
ACHENBACH BRIAN Officer | Sale at price 2.64 - 3.69 per share. | Direct | 66,282 | Apr 9, 2021 |
LITCHMAN MANUEL Chief Executive Officer | Purchase at price 3.12 per share. | Direct | 516,553 | Mar 5, 2021 |
LITCHMAN MANUEL Chief Executive Officer | Stock Award(Grant) at price 2.83 per share. | Direct | 14,150 | Feb 26, 2021 |
ROSENWALD LINDSAY A M.D. Director | Stock Award(Grant) at price 2.83 per share. | Direct | 2,952 | Feb 26, 2021 |
ACHENBACH BRIAN Officer | -- | Direct | -- | Dec 15, 2020 |
LITCHMAN MANUEL Chief Executive Officer | Purchase at price 2.91 per share. | Direct | 291,000 | Dec 15, 2020 |
ROSENWALD LINDSAY A M.D. Director | Purchase at price 2.66 per share. | Direct | 266,000 | Dec 14, 2020 |
ROSENWALD LINDSAY A M.D. Director | Purchase at price 2.66 per share. | Direct | 266,000 | Dec 14, 2020 |
LITCHMAN MANUEL Chief Executive Officer | Stock Award(Grant) at price 2.48 per share. | Direct | 12,400 | Sep 15, 2020 |
ROSENWALD LINDSAY A M.D. Director | Stock Award(Grant) at price 2.48 per share. | Direct | 2,931 | Aug 31, 2020 |
WEISS MICHAEL S Director | -- | Direct | -- | Jul 14, 2020 |
HERSKOWITZ NEIL Director | -- | Direct | -- | Jul 14, 2020 |
CHILL ADAM J Director | -- | Direct | -- | Jul 14, 2020 |
ZELEFSKY MICHAEL J Director | -- | Direct | -- | Jul 14, 2020 |
ROSENWALD LINDSAY A M.D. Director | -- | Direct | -- | Jul 14, 2020 |
ROSENWALD LINDSAY A M.D. Director | Stock Award(Grant) at price 2.48 per share. | Direct | 43,256 | Jul 14, 2020 |
LITCHMAN MANUEL Chief Executive Officer | Purchase at price 3.25 per share. | Direct | 500,000 | Jun 11, 2020 |
LITCHMAN MANUEL Chief Executive Officer | Sale at price 3.04 per share. | Direct | 37,614 | May 22, 2020 |
LITCHMAN MANUEL Chief Executive Officer | Purchase at price 2.79 - 3.13 per share. | Direct | 532,800 | May 21, 2020 |
ACHENBACH BRIAN Officer | Stock Award(Grant) at price 2.48 per share. | Direct | 1,300 | Mar 26, 2020 |
LITCHMAN MANUEL Chief Executive Officer | Stock Award(Grant) at price 2.48 per share. | Direct | 12,400 | Mar 26, 2020 |
ROSENWALD LINDSAY A Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 28, 2019 |
Related Tickers
FBIO Fortress Biotech, Inc.
1.7500
0.00%
CKPT Checkpoint Therapeutics, Inc.
1.4500
-0.68%
ATXI Avenue Therapeutics, Inc.
0.1301
+0.08%
VAXX Vaxxinity, Inc.
0.2696
-43.37%
SLN Silence Therapeutics plc
22.50
-0.62%
PRTG Portage Biotech Inc.
0.2972
+6.91%
PTN Palatin Technologies, Inc.
1.7200
-6.52%
TRVN Trevena, Inc.
0.3702
+5.17%
GLMD Galmed Pharmaceuticals Ltd.
0.3641
-2.02%
FBIOP Fortress Biotech, Inc.
14.65
-7.80%